245 related articles for article (PubMed ID: 22938448)
1. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis.
Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH
Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea.
Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170
[TBL] [Abstract][Full Text] [Related]
3. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
4. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
6. Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea.
Lee HY; Park EC; Jun JK; Choi KS; Hahm MI
World J Gastroenterol; 2010 Jan; 16(2):245-50. PubMed ID: 20066745
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS
Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235
[TBL] [Abstract][Full Text] [Related]
8. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.
Jun JK; Choi KS; Lee HY; Suh M; Park B; Song SH; Jung KW; Lee CW; Choi IJ; Park EC; Lee D
Gastroenterology; 2017 May; 152(6):1319-1328.e7. PubMed ID: 28147224
[TBL] [Abstract][Full Text] [Related]
10. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
11. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
13. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
Areia M; Carvalho R; Cadime AT; Rocha Gonçalves F; Dinis-Ribeiro M
Helicobacter; 2013 Oct; 18(5):325-37. PubMed ID: 23566268
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea.
Ra H; Song LD; Choi JA; Jee D
PLoS One; 2018; 13(10):e0206690. PubMed ID: 30379971
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
Shah SC; Canakis A; Peek RM; Saumoy M
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341
[TBL] [Abstract][Full Text] [Related]
16. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness and cost-benefit analysis of upper gastrointestinal cancer screening in Yangzhong City, Jiangsu Province, from 2009 to 2015].
Feng X; Hua ZL; Qian DF; Zhou Q; Shi AW; Wei WW; Zhou JY
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1115-1118. PubMed ID: 31683397
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.
Saito S; Azumi M; Muneoka Y; Nishino K; Ishikawa T; Sato Y; Terai S; Akazawa K
Eur J Health Econ; 2018 May; 19(4):545-555. PubMed ID: 28550494
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of prostate cancer screening test as a national cancer screening program in South Korea.
Shin S; Kim YH; Hwang JS; Lee YJ; Lee SM; Ahn J
Asian Pac J Cancer Prev; 2014; 15(8):3383-9. PubMed ID: 24870726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]